Grigoris Gerotziafas Shares The APICAT Study Post Hoc Analysis
Grigoris Gerotziafas, Director of the Cancer, Vessels, Biology, and Therapeutics (CaVITE) Research Department, Head of the CRSA at Sorbonne University, shared on LinkedIn:
”APICAT study post hoc analysis, Just published: During extended treatment for cancer-associated VTE, four predictors of clinically relevant bleeding were identified in the overall population of patients treated with apixaban, with no evidence of interaction with the dosing regimen.
Anaemia and/or thrombocytopenia, age 75 years or older, pulmonary embolism as the index event, and male sex were significantly associated with an increased risk of clinically relevant bleeding.
Isabelle Mahé 1 , Céline Chapelle 2 , Philippe Girard 3 , Marc Carrier 4 , Luis Jara Palomares 5 , Charles-Marc Samama 6 , Hélène Helfer 7 , Grigoris Gerotziafas 8 , Silvy Laporte 9 , Eric Vicaut 10 , Patrick Mismetti 11 ; API-CAT Study Group; API-CAT Investigators. Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trial.
Lancet Haematol. 2026 Jan;13(1):e41-e48.”
Read the full article here.
Article: Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trial
Authors: Isabelle Mahé, Céline Chapelle, Philippe Girard, Marc Carrier, Luis Jara Palomares, Charles-Marc Samama
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 17, 2026, 12:36Tomasz Brzoska on The Role of Circulating TF in Pulmonary Arterial Thrombosis
-
Jan 17, 2026, 12:25Ahmed Nasreldein Honored to Moderate Scientific Session at ASO’s Webinar on Stroke Imaging
-
Jan 17, 2026, 12:16Michael Makris on UK’s National Self-Assesment Questionnaire on VTE
-
Jan 17, 2026, 11:45Emmanuel J Favaloro Shares Yet Another Paper from The 100th Anniversary of VWD
-
Jan 17, 2026, 05:05Dr Abdul Mannan: Iron Deficiency Can Hide Beta-Thalassaemia Trait
-
Jan 17, 2026, 05:01Fortis Memorial Research Institute, Gurugram Ranked Among the World’s Top 50 Smart Hospitals
-
Jan 17, 2026, 04:59Flora Peyvandi: Factor VIII in Vitro Bioequivalence of Mim8 Haemostatic Effect
-
Jan 17, 2026, 04:58Desmopressin in Bleeding Disorders: 5,000 Views in 6 Months – Why This Topic Matters
-
Jan 17, 2026, 04:58Sifat Jubaira Shares Chylous Blood Clinical Case: Milky Blood Instead of Red